Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

5 Undervalued UK Shares Not to be Overlooked

Published 11/06/2024, 09:59
© Reuters.
UK100
-
BATS
-
BP
-
GSK
-

Investing.com - Tuesday's session sees a positive wave coursing through the main European Indices, with the FTSE100 displaying signs of a comeback after its dip post-European elections.

As we step into mid-June, it appears apt to scrutinise the performance of some FTSE100 constituents. Taking a closer look at its blue-chip stocks, we've uncovered some hidden gems worth your attention. The common strand between them all? They're undervalued stocks.

What is an Undervalued Stock?

An undervalued stock is one whose current trading value is less than its intrinsic worth. This means that the existing share price is believed to be less than the value derived from its fundamental assets, earnings, growth potential, or even cash flows.

This undervaluation may result from various factors including market volatility, economic circumstances, changes in investor sentiment, or negative news circulating around the company or its industry.

Devotees of a value-investing strategy often hunt down such stocks, betting on the market eventually recognising and mirroring the company's true intrinsic value. However, flagging undervalued stocks necessitates a detailed analysis, which includes assessing financial fundamentals, industry standing, market conditions, and future business forecasts.

Of course, it's important to remember that investing in undervalued stocks, like all investment strategies, carries risk. Prior to making any investment decisions, always carefully weigh up your financial objectives and risk appetite.

Indentifying Undervalued Stocks with InvestingPro’s AI

Leveraging our cutting-edge AI technology, we've been able to identify five shares that could potentially enrich our portfolios.

According to InvestingPro, the first share to monitor is British American Tobacco (LON:BATS). With a Fair Value of £30.28, it boasts a 26% upside potential, earning a 'Good' label for its Overall Health performance. BP (LON:BP) charts a similar course, flaunting nearly a 40% upside potential and a Fair Value of £6.49.

GlaxoSmithKline is the third contender for your watchlist. It wields an Upside potential of 46.2%, paired with a 'Great' label in its Overall Health.

Undervalued Stocks in the UK according to InvestingPro

And we have more! We've unearthed two additional undervalued stocks that could make a great addition to your investment portfolio. By subscribing to InvestingPro, investors can create customised watchlists and alerts to stay informed about these stocks and thousands more, and know when to buy and when to sell for maximum portfolio ROI.

--------------------------------------------------------------------------------

PROMO! Shift your investing game into high gear with InvestingPro! Harnessing the power of advanced AI technology, InvestingPro equips retail investors like you with data-driven insights, helping you make savvier investments decisions. Our tool does the complex analysis so you can focus on making the smart choices. From identifying undervalued stocks to predicting market trends, InvestingPro is your go-to companion in the stock market journey. Don't just invest, invest like a Pro with Investing.com. Get 10% extra discount using UK10.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.